We’re not your typical healthcare VC firm.
Through our strategic investments and partnerships, ShangPharma Innovation is focused on filling the critical investment gap that exists for earliest-stage therapeutic breakthroughs.
Based in the San Francisco Bay Area, our experienced team of investors and scientists brings knowledge of diverse therapeutic areas, allowing us to act on opportunities that no one else sees. We leverage multidimensional relationships across the spectrum of biotech and pharma to identify promising healthcare discoveries — and then work side-by-side with scientific innovators to rapidly advance those ideas through key value-inflection points.
ShangPharma Innovation embraces a founder-centric approach that ensures entrepreneurs can remain actively involved in shaping their company’s successes, all with the proactive and trusted support of our wide network of experts.
“Circle Pharma wouldn’t be where we are today without ShangPharma, which has helped with nearly every aspect of our company’s development. We’ve benefited not only from their capital investment, but also from their incubator services and guidance from their remarkably experienced EIRs.”
-David J. Earp, J.D., Ph.D., President and CEO of Circle Pharma
Founding Senior Team
Michael Hui, MBA
Chairman of ShangPharma Innovation, Chairman and CEO of ShangPharma Holdings
Sarah Lively, Ph.D.
Senior Advisor
